Avantor Revenue 2018-2025 | AVTR

Avantor annual/quarterly revenue history and growth rate from 2018 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Avantor revenue for the quarter ending March 31, 2025 was $1.581B, a 5.86% decline year-over-year.
  • Avantor revenue for the twelve months ending March 31, 2025 was $6.685B, a 2.64% decline year-over-year.
  • Avantor annual revenue for 2024 was $6.784B, a 2.64% decline from 2023.
  • Avantor annual revenue for 2023 was $6.967B, a 7.26% decline from 2022.
  • Avantor annual revenue for 2022 was $7.512B, a 1.71% increase from 2021.
Avantor Annual Revenue
(Millions of US $)
2024 $6,784
2023 $6,967
2022 $7,512
2021 $7,386
2020 $6,394
2019 $6,040
2018 $5,864
2017 $1,247
Avantor Quarterly Revenue
(Millions of US $)
2025-03-31 $1,581
2024-12-31 $1,687
2024-09-30 $1,714
2024-06-30 $1,703
2024-03-31 $1,680
2023-12-31 $1,723
2023-09-30 $1,720
2023-06-30 $1,744
2023-03-31 $1,780
2022-12-31 $1,795
2022-09-30 $1,857
2022-06-30 $1,911
2022-03-31 $1,950
2021-12-31 $1,908
2021-09-30 $1,834
2021-06-30 $1,859
2021-03-31 $1,786
2020-12-31 $1,791
2020-09-30 $1,605
2020-06-30 $1,479
2020-03-31 $1,519
2019-12-31 $1,524
2019-09-30 $1,504
2019-06-30 $1,532
2019-03-31 $1,480
2018-12-31
2018-09-30 $1,494
2018-06-30 $1,478
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $9.165B $6.784B
Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $142.561B 26.74
Elevance Health (ELV) United States $88.026B 11.36
CVS Health (CVS) United States $80.784B 10.04
Cencora (COR) United States $55.036B 19.15
DiDi Global (DIDIY) China $23.580B 35.79
Natera (NTRA) United States $22.420B 0.00
BioMerieux (BMXMF) France $16.097B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.007B 0.00
Solventum (SOLV) United States $12.962B 13.72
CochLear (CHEOY) Australia $11.342B 0.00
ICON (ICLR) Ireland $11.283B 10.49
Revvity (RVTY) United States $10.948B 18.84
Doximity (DOCS) United States $10.905B 50.49
Viatris (VTRS) United States $10.340B 3.55
HealthEquity (HQY) United States $9.613B 42.11
Medpace Holdings (MEDP) United States $8.574B 22.77
Sonic Healthcare (SKHHY) Australia $8.388B 0.00
Charles River Laboratories (CRL) United States $7.243B 14.19
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.238B 24.96
BrightSpring Health Services (BTSG) United States $4.157B 38.48
Sotera Health (SHC) United States $3.508B 19.93
Surgery Partners (SGRY) United States $2.994B 38.93
Alignment Healthcare (ALHC) United States $2.924B 0.00
Concentras Parent (CON) United States $2.830B 16.36
Organon (OGN) United States $2.537B 2.70
GeneDx Holdings (WGS) United States $2.066B 79.58
Ardent Health Partners (ARDT) United States $1.957B 8.34
Premier (PINC) United States $1.900B 14.43
Progyny (PGNY) United States $1.883B 41.45
PACS (PACS) United States $1.586B 0.00
GoodRx Holdings (GDRX) United States $1.468B 29.36
Teladoc Health (TDOC) United States $1.298B 0.00
Pediatrix Medical (MD) United States $1.214B 9.24
Establishment Labs Holdings (ESTA) $1.113B 0.00
CareDx (CDNA) United States $1.098B 17.15
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.944B 0.00
AMN Healthcare Services Inc (AMN) United States $0.818B 7.66
QDM (QDMI) Hong Kong, SAR China $0.752B 0.00
Nutex Health (NUTX) United States $0.654B 9.90
Embecta (EMBC) United States $0.579B 3.90
LifeMD (LFMD) United States $0.566B 0.00
Enhabit (EHAB) United States $0.546B 44.92
InnovAge Holding (INNV) United States $0.520B 0.00
SBC Medicals (SBC) United States $0.507B 0.00
Sonida Senior Living (SNDA) United States $0.472B 0.00
Auna S.A (AUNA) Luxembourg $0.471B 10.60
COMPASS Pathways (CMPS) United Kingdom $0.437B 0.00
Performant Healthcare (PHLT) United States $0.244B 0.00
Oncology Institute (TOI) United States $0.232B 0.00
Beauty Health (SKIN) United States $0.202B 0.00
DocGo (DCGO) United States $0.163B 26.67
KindlyMD (KDLY) United States $0.150B 0.00
Pheton Holdings (PTHL) China $0.099B 0.00
So-Young (SY) China $0.091B 0.00
Basel Medical Group (BMGL) Singapore $0.081B 0.00
KindlyMD (NAKA) United States $0.081B 0.00
OncoCyte (OCX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.058B 0.00
Sera Prognostics (SERA) United States $0.057B 0.00
ModivCare (MODV) United States $0.050B 0.00
Biodesix (BDSX) United States $0.042B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00